Literature DB >> 21772004

Gulf Survey of Atrial Fibrillation Events (Gulf SAFE): design and baseline characteristics of patients with atrial fibrillation in the Arab Middle East.

Mohammad Zubaid1, Wafa A Rashed, Alawi A Alsheikh-Ali, Wael Almahmeed, Abdullah Shehab, Kadhim Sulaiman, Ibrahim Al-Zakwani, Ahmed Alqudaimi, Nidal Asaad, Haitham Amin.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is the most common serious cardiac arrhythmia, and its prevalence is expected to increase. There is lack of data about patient characteristics, practice patterns, and outcomes of AF in the Arab Middle East. METHODS AND
RESULTS: The Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) is a prospective, observational registry of patients with AF with a 12-month follow-up. The registry was emergency room based. Between October 2009 and June 2010, 2043 consecutive patients with AF were enrolled from 23 hospitals in 6 Middle Eastern Gulf countries. Data were collected on a standardized case report form and entered online. Data collected included patient demographics, medical history, type of AF, treatment, and outcome of emergency room visit. If patients were admitted, details of their treatment, investigations, and outcomes during hospital stay were collected. Completion of 12-month follow-up is expected by July 2011. The mean age was 57 years, and 52% were men. The most common concomitant condition was hypertension, present in 1072 (52%) patients. At enrollment, 28% of patients had a history of coronary artery disease, 30% had diabetes, and 16% had rheumatic valve disease. History of stroke and transient ischemic attacks were reported in 9% and 4% of patients, respectively. The most common type of AF, first attack AF, occurred in 37%, whereas 19% of patients had lone AF.
CONCLUSIONS: Gulf SAFE will provide valuable insights into AF management and outcomes in the Gulf region of the Middle East.

Entities:  

Mesh:

Year:  2011        PMID: 21772004     DOI: 10.1161/CIRCOUTCOMES.110.959700

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  21 in total

Review 1.  Prospective observational studies of the management and outcomes in patients with atrial fibrillation: A systematic review.

Authors:  Ahmad S Hersi; Alawi A Alsheikh-Ali; Mohammad Zubaid; Jassim Al Suwaidi
Journal:  J Saudi Heart Assoc       Date:  2012-08-23

Review 2.  Global epidemiology of atrial fibrillation.

Authors:  Faisal Rahman; Gene F Kwan; Emelia J Benjamin
Journal:  Nat Rev Cardiol       Date:  2014-08-12       Impact factor: 32.419

3.  Patient characteristics, adherence, and costs of oral anticoagulation therapy in non-valvular atrial fibrillation using the Dubai Real-World Claims Database.

Authors:  Moutaz El Kadri; Ahmed Ghorab; Jean Joury; Mohamed Farghaly; Nancy Awad; Badarinath Chickballapur Ramachandrachar; Ashok Natarajan
Journal:  Avicenna J Med       Date:  2021-04-19

4.  Clinical Differences between Subtypes of Atrial Fibrillation and Flutter: Cross-Sectional Registry of 407 Patients.

Authors:  Eduardo Dytz Almeida; Raphael Boesche Guimarães; Laura Siga Stephan; Alexandre Kreling Medeiros; Katia Foltz; Roberto Tofani Santanna; Leonardo Martins Pires; Marcelo Lapa Kruse; Gustavo Glotz de Lima; Tiago Luiz Luz Leiria
Journal:  Arq Bras Cardiol       Date:  2015-05-19       Impact factor: 2.000

5.  Gulf Implantable Cardioverter-defibrillator Registry Reflects Advanced Cardiac Care in the Arab Gulf.

Authors:  Hajar A Albinali
Journal:  Heart Views       Date:  2015 Oct-Dec

6.  The Cumulative Incidence of Stroke, Myocardial infarction, Heart Failure and Sudden Cardiac Death in Patients with Atrial Fibrillation.

Authors:  Nabil Naser; Mehmed Kulic; Mirza Dilic; Alen Dzubur; Azra Durak; Esad Pepic; Elnur Smajic; Zumreta Kusljugic
Journal:  Med Arch       Date:  2017-10

7.  Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya.

Authors:  Tecla M Temu; Kathleen A Lane; Changyu Shen; Loise Ng'ang'a; Constantine O Akwanalo; Peng-Sheng Chen; Wilfred Emonyi; Susan R Heckbert; Myra M Koech; Imran Manji; Matteo Vatta; Eric J Velazquez; Jennifer Wessel; Sylvester Kimaiyo; Thomas S Inui; Gerald S Bloomfield
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

8.  Prognostic factors of clinical endpoints in elderly patients with atrial fibrillation during a 2-year follow-up in China: An observational cohort study.

Authors:  Hao Wang; Hai-Jun Wang; Ya-Dong Chen; Tao Tao; Yu-Tao Guo; Xiao-Ning Zhao; Hong-Bin Liu; Yu-Tang Wang
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

Review 9.  Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches?

Authors:  Gregory Y H Lip; Sana M Al-Khatib; Francisco G Cosio; Amitava Banerjee; Irina Savelieva; Jeremy Ruskin; Dan Blendea; Stanley Nattel; Joseph De Bono; Jennifer M Conroy; Paul L Hess; Eduard Guasch; Jonathan L Halperin; Paulus Kirchhof; M Dolores G Cosio; A John Camm
Journal:  J Am Heart Assoc       Date:  2014-08-27       Impact factor: 5.501

10.  Cardiovascular risk factor burden in Africa and the Middle East: the Africa Middle East Cardiovascular Epidemiological (ACE) study.

Authors:  Alawi A Alsheikh-Ali; Mohamed I Omar; Frederick J Raal; Wafa Rashed; Omar Hamoui; Abdoul Kane; Mohamed Alami; Paula Abreu; Walid M Mashhoud
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.